SDP-4 is a soluble silk fibroin-derived protein hydrolysate extracted from the silkworm cocoon and is a novel first-in-class biopolymer that is biodegradable, biocompatible, and shown to have regenerative properties. SDP-4 is currently used as a commercial wetting agent in topical eye drops, but it has also been shown to have anti-inflammatory properties that could be utilized in other biomedical applications. The purpose of this study was to comprehensively characterize the physicochemical properties that are necessary to design formulations and examine cell viability in response to varying doses of SDP-4 on different human cell types, with a particular attention toward respiratory applications. Lyophilized SDP-4 powder was characterized by scanning electron microscopy (SEM), energy-dispersive X-ray (EDX) spectroscopy, differential scanning calorimetry (DSC), hot-stage microscopy (HSM), Karl Fisher (KF) coulometric titration, Raman spectrometry, confocal Raman microscopy (CRM), and Fourier transform infrared microscopy. The lyophilized powder exhibited a nonuniform, angular glassy flake morphology with uniform chemical composition and minimal moisture uptake when tested under varying humidity conditions. Crystalline character was evident through birefringence at ambient temperature which changed during phase transitions, as evidenced through qualitative and quantitative assessments. Dose ranging SDP-4 biocompatibility studies on different human lung cells, nasal cells, skin cells, and brain cells was assessed by the in vitro cell viability assay. Assay results showed that cell viability was maintained at the various doses studied for different human cell types. The transepithelial resistance (TEER) assay showed that SDP-4 leads to transient fluctuations in cell membrane integrity and barrier tightness, followed by a recovery phase as cells adapt or repair the junctions. These findings demonstrate that SDP-4 is biocompatible with different types of human cells and safe at all of the doses studied. The unique physicochemical properties of SDP-4 revealed in this study demonstrate its favorable formulating ability for a variety of potential therapeutic applications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11780451PMC
http://dx.doi.org/10.1021/acsomega.4c08514DOI Listing

Publication Analysis

Top Keywords

human cell
12
cell viability
12
sdp-4
9
protein hydrolysate
8
properties sdp-4
8
physicochemical properties
8
cell types
8
doses studied
8
cell
7
cells
6

Similar Publications

Background: Cervical adenocarcinoma (ADC) is more aggressive compared to other types of cervical cancer (CC), such as squamous cell carcinoma (SCC). The tumor immune microenvironment (TIME) and tumor heterogeneity are recognized as pivotal factors in cancer progression and therapy. However, the disparities in TIME and heterogeneity between ADC and SCC are poorly understood.

View Article and Find Full Text PDF

Background: Tumor metastasis is one of the main causes of death in cancer patients; however, the mechanism controlling metastasis is unclear. The posttranscriptional regulation of metastasis-related genes mediated by AT-rich interactive domain-containing protein 4A (Arid4a), an RNA-binding protein (RBP), has not been elucidated.

Methods: Bioinformatic analysis, qRT-PCR, immunohistochemistry, and immunoblotting were employed to determine the expression of Arid4a in breast tumor tissues and its association with the survival of cancer patients.

View Article and Find Full Text PDF

Peroxiredoxins (Prx) are ubiquitous Cys peroxidases regulated by sulfinylation, a modification that occurs when the sulfenic acid generated on the catalytic Cys by peroxide reduction reacts with a second molecule of peroxide. In the Prx1 family, sulfinylation sensitivity is controlled by competition between a structural transition from a fully folded (FF) to locally unfolded (LU) conformation and the chemical step of sulfinylation. The initial peroxide reduction relies on a conserved catalytic hydroxylated residue that allows peroxide optimal activation.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on β2-microglobulin (β2-MG) as a predictor of prognosis in patients with diffuse large B-cell lymphoma (DLBCL), involving 98 patients over two years.
  • The critical threshold for β2-MG was identified as 3.285 µg/L, with patients below this level showing better survival rates compared to those above it during follow-up.
  • Elevated levels of β2-MG, along with LDH and CRP, were determined to be independent risk factors influencing overall survival in DLBCL patients, leading to the development of a prognostic prediction model that effectively correlated predicted outcomes with actual results.
View Article and Find Full Text PDF

Background: Several particular kinds of typical morphology characteristics of leukemic blasts associated with the specific subtypes of leukemia have been reported. However, B acute lymphoblastic leukemia/lymphoma (B-ALL/LBL) has rarely been reported. The purpose of this study was to investigate the correlation of TCF3::PBX1 fusion with multiple clefts nuclei of blasts in patients with B-ALL/LBL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!